AMGN
Amgen Inc.
Stock
$407.27−14.24 (−3.38%)Close Oct 1, 2026
Key figures
| Metric | TTM | YoY |
|---|---|---|
| Revenue | $38.1B | +9.1% |
| Gross profit | $26.5B | +17.6% |
| Operating income | $11.4B | +39.5% |
| Net income | $8.7B | +32.1% |
| EPS | $16.09 | +31.7% |
| Free cash flow | $10.2B | −4.1% |
Amgen Inc.
$407.27−14.24 (−3.38%)Close Oct 1, 2026
| Metric | TTM | YoY |
|---|---|---|
| Revenue | $38.1B | +9.1% |
| Gross profit | $26.5B | +17.6% |
| Operating income | $11.4B | +39.5% |
| Net income | $8.7B | +32.1% |
| EPS | $16.09 | +31.7% |
| Free cash flow | $10.2B | −4.1% |